LO11 - ENHANCE: SAFETY AND EFFICACY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) - A PHASE 3 INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED STUDY

Hirschfield, G. M., Kowdley, K. V., Khazanchi, Aspinall, R. J., Gordon, S. C., De Guevara, Shiffman, M. L., Ruiz, Ryder, S. D., Zigmond, E., Pratt, Forman, L., Gulamhusein, A., Levy, C., Stanca1, Gonzalez-Huezo, M. S., Heo, Leggett, B. A., Minuk, Pagadala & 9 others, Pound, Райхельсон, К. Л., Silveira, Swain, M. G., Yimam, Younes, Zuckerman, E., Corpechot, C. & Harrison, 16 Nov 2020.

Research output: Contribution to conference › Abstract › peer-review